An interactive OLA designed especially for clinicians managing MI patients during COVID-19.
Upon conclusion of this program, participants will be able to:
- DESCRIBE the concept of residual cardiovascular risk
- INFORM therapeutic decisions for residual risk management based on risk thresholds
- IMPLEMENT practical and evidence-based recommendations to minimize the recurrence of cardiovascular events in a new era of virtual care
- RECOGNIZE that aggressive management of residual risk is warranted in MI patients despite the COVID-19-imposed restrictions